Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013860 220008291 null 74 Curative (C) 2014-10-17 2014-10-17 Rituximab N N 220031504 RITUXIMAB
220013861 220008291 1.68 0 null 2017-03-03 2017-07-03 AML 18 TRIAL null N 220031504 AML18 TRIAL
220013862 220019839 0 63 null 2013-06-05 2013-06-05 AML18 PILOT TRIAL N N 220031508 PILOT TRIAL
220013863 220008293 null null Curative (C) 2018-05-25 2018-10-24 Dasatinib N N 220031509 DASATINIB
220013864 220014510 1.82 null Palliative (P) 2014-03-01 2015-04-01 Dasatinib 99 null 220031510 DASATINIB
220013865 220014510 1.6 null Disease modification (D) 2018-04-07 2018-05-16 Rituximab N N 220031510 RITUXIMAB
220013866 220014510 1.8 95.1 Curative (C) 2013-08-05 2013-08-09 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220031510 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013867 220008295 1.66 null Neo-adjuvant (N) 2013-03-09 2013-12-11 Dasatinib 99 N 220031522 DASATINIB
220013868 220008296 1.96 null Adjuvant (A) 2019-02-13 2019-02-13 Dasatinib N null 220031524 DASATINIB
220013869 220008297 null 75 Palliative (P) 2017-12-12 2017-12-12 AML 18 TRIAL 1 N 220031525 AML18 TRIAL
220013871 220014511 1.78 64.9 Adjuvant (A) 2016-04-30 2016-08-14 AML18 PILOT TRIAL N null 220031527 PILOT TRIAL
220013872 220008299 1.58 69.9 Palliative (P) 2013-07-01 2013-07-01 Dasatinib 2 N 220031530 DASATINIB
220013873 220008300 1.64 0 Curative (C) 2018-03-12 2018-03-12 Dasatinib N N 220031530 DASATINIB
220013875 220008302 1.69 70 Curative (C) 2014-05-16 2014-05-16 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220031548 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013876 220008303 1.75 127 Disease modification (D) 2015-10-07 2015-10-25 Alemtuz+Fludara+Melphalan RIC MUD N N 220031551 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013877 220008306 1.67 null Palliative (P) 2012-12-01 2013-12-02 Dasatinib N null 220031554 DASATINIB
220013878 220008307 null 0 Palliative (P) 2014-08-20 2014-08-20 Dasatinib 02 null 220031559 DASATINIB
220013879 220014513 0 null Palliative (P) 2014-01-21 2014-01-21 Dasatinib N N 220031562 DASATINIB
220013880 220014513 1.75 null Curative (C) 2013-07-01 2013-09-26 AML 18 TRIAL N N 220031562 AML18 TRIAL
220013881 220014513 1.62 100 Disease modification (D) 2013-03-06 2013-03-07 AML 18 TRIAL 01 N 220031562 AML18 TRIAL
220013882 220008308 null 63 null 2014-11-10 2015-03-11 AML18 PILOT TRIAL N null 220031581 PILOT TRIAL
220013883 220014514 1.61 106 Curative (C) 2013-10-17 2013-10-17 Alemtuz+Fludara+Melphalan RIC MUD N N 220031587 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013884 220008311 1.66 73 Curative (C) 2016-04-07 2016-04-07 AML 18 TRIAL 1 N 220031587 AML18 TRIAL
220013885 220008313 null 63.1 Curative (C) 2016-05-15 2016-05-22 Alemtuz+Fludara+Melphalan RIC MUD null N 220031589 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220013886 220008314 null 81 null 2016-02-11 2016-08-18 Rituximab 2 N 220031596 RITUXIMAB
220013889 220008316 null 61.2 null 2017-10-27 2017-11-02 FLAG N N 220031604 FLAG
220013890 220008317 null 90.8 Disease modification (D) null 2014-07-23 ATG + Busulfan + Fludarabine null null 220031606 ATG + BUSULFAN + FLUDARABINE
220013891 220017932 0 90 Palliative (P) 2012-12-31 2013-03-01 Triple Intrathecal 2 Y 220031607 TRIPLE INTRATHECAL
220013892 220008324 0 71.5 Disease modification (D) 2018-10-25 2018-11-06 RUXOLITINIB 2 N 220031607 RUXOLITINIB
220013893 220008325 1.77 77.6 Palliative (P) null 2018-10-06 BOSUTINIB N N 220031609 BOSUTINIB
220013894 220020943 1.64 80 Disease modification (D) 2017-09-30 2017-09-30 Methotrexate intrathecal N N 220031618 METHOTREXATE INTRATHECAL
220013895 220020943 1.62 75 Curative (C) 2016-09-17 2016-09-17 CYCLOPHOSPHAMIDE N N 220031618 CYCLOPHOSPHAMIDE
220013896 220020943 1.6 null Disease modification (D) 2014-02-24 2014-02-25 Methotrexate intrathecal 02 N 220031618 METHOTREXATE INTRATHECAL
220013897 220014524 1.7 null Curative (C) 2015-08-25 2015-08-25 Methotrexate intrathecal 2 N 220031622 METHOTREXATE INTRATHECAL
220013898 220008329 1.51 null Curative (C) 2013-12-05 2013-12-05 Triple Intrathecal N N 220031623 TRIPLE INTRATHECAL
220013899 220008331 null 50.5 Curative (C) 2017-12-24 2017-12-25 BOSUTINIB null N 220031625 BOSUTINIB
220013900 220008333 1.66 75 Curative (C) 2016-06-05 2016-06-05 Methotrexate intrathecal 2 N 220031628 METHOTREXATE INTRATHECAL
220013901 220014526 1.63 0 Curative (C) 2013-08-02 2013-09-22 Cyclophosphamide TBI Allograft 02 Y 220031628 CYCLOPHOSPHAMIDE
220013902 220008334 1.74 0 Curative (C) 2017-04-06 2017-04-06 ATG + Busulfan + Fludarabine N N 220031645 ATG + BUSULFAN + FLUDARABINE
220013906 220008338 1.68 null Disease modification (D) 2014-01-06 2014-01-07 Triple / Double Intrathecal Therapy 02 N 220031663 TRIPLE INTRATHECAL
220013907 220008339 1.6 55.5 Not known (9) 2015-07-14 2015-11-30 AML16 DA 3+8 N Y 220031663 AML16 TRIAL
220013908 220008340 1.75 93 Disease modification (D) 2014-06-08 2014-06-08 BOSUTINIB N N 220031680 BOSUTINIB
220013909 220014530 1.78 118.5 Curative (C) null 2016-10-15 Cyclophosphamide oral N null 220031680 CYCLOPHOSPHAMIDE
220013910 220008342 1.7 null Palliative (P) 2013-11-21 2013-11-24 FLAG 2 N 220031681 FLAG
220013911 220008343 1.51 null Curative (C) null 2013-03-06 FLAG N N 220031687 FLAG
220013912 220008348 1.65 65.4 Disease modification (D) 2014-07-05 2014-07-05 Methotrexate intrathecal N N 220031688 METHOTREXATE INTRATHECAL
220013913 220014533 1.77 61.5 Curative (C) 2015-05-20 2015-05-20 BOSUTINIB 2 N 220031689 BOSUTINIB
220013914 220017938 1.65 82 Curative (C) 2015-08-26 2015-08-26 FLAG 2 N 220031691 FLAG
220013915 220017938 null 25.8 Palliative (P) 2015-10-26 2015-10-26 Idarubicin+Tretinoin Spanish Crse4 N N 220031691 IDARUBICIN + TRETINOIN
220013916 220008350 1.75 69 Curative (C) 2017-03-12 2017-03-12 AML Int Guide ADE 8+3+5 (2) N N 220031700 ADE